Products - Endometriosis and fibroids | Topic | NICE

Showing 4 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Linzagolix for treating moderate to severe symptoms of uterine fibroids (TA996)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
14 August 2024
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids (TA832)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
19 October 2022
Linzagolix for treating symptoms of endometriosis [ID6357]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
25 June 2025
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis [ID3982]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC